FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pfizer | Merck | DTC advertising | Stupak

DTC hearing has high-powered guest list

Tools

Hail, hail the gang's all here...at the House Subcommittee on Oversight and Investigations hearing on direct-to-consumer ads. Next week, Rep. Bart Stupak will preside over testimony from Pfizer, Merck, Schering-Plough, and Johnson & Johnson. Kaiser Permanente, the GAO, and the AMA may be there, too.

The official title of the hearing? "Direct-to-Consumer Advertising: Marketing, Education, or Deception?' Not surprising, considering Stupak's history as an industry critic, but definitely not comfortable for those scheduled to say their piece. If you're interested, the committee will offer a video feed.

- see the Pharmalot item
- get the link to the webcast at the committee's site

Related Articles:
Study: Drug ads drown in online noise
To DTC or not to DTC?
Should FDA's info be in all DTC ads?
FDA to study TV drug ad imagery
Survey: No doubt DTC ads work

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Pfizer   Merck   DTC advertising   Stupak  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.